Pearl River Capital’s DexCom DXCM Stock Holding History

Pearl River Capital’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,241	Closed	-$254K	–	528
2022 Q4	$254K	Buy	+2,241	New	+$246K	0.04%	439
2022 Q3	–	Sell	-4,550	Closed	-$339K	–	482
2022 Q2	$339K	Buy	+4,550	New	+$415K	0.08%	330
2022 Q1	–	Sell	-17,692	Closed	-$2.38M	–	441
2021 Q4	$2.38M	Buy	+17,692	New	+$2.54M	0.64%	32
2020 Q4	–	Sell	-8,492	Closed	-$875K	–	406
2020 Q3	$875K	Buy	+8,492	New	+$887K	0.37%	92
2020 Q2	–	Sell	-1,964	Closed	-$132K	–	368
2020 Q1	$132K	Buy	+1,964	New	+$122K	0.25%	134
2019 Q4	–	Sell	-12	Closed	–	–	565
2019 Q3	$0	Buy	+12	New	+$466	﹤0.01%	450
2019 Q2	–	Sell	-5,104	Closed	-$152K	–	328
2019 Q1	$152K	Buy	+5,104	New	+$179K	0.38%	123

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Pearl River Capital's DXCM Position: Q1 2023 in Review

Pearl River Capital sold out of DexCom (DXCM) in Q1 2023, closing a stake of 2,241 shares — an estimated $254K sold.

Pearl River Capital first reported a position in DXCM in Q1 2019 and held it in 7 quarters. The position peaked at $2.38M in Q4 2021. 905 funds tracked by Wall St. Rank hold DXCM as of Q1 2023.

Pearl River Capital reported no remaining DexCom position as of Q1 2023 after selling out during the quarter.
Pearl River Capital sold 2,241 DexCom shares in Q1 2023, an estimated $254K.
Pearl River Capital first reported a position in DexCom in Q1 2019 and held it in 7 quarters.
Pearl River Capital's DexCom position peaked at $2.38M in Q4 2021.
905 funds tracked by Wall St. Rank held DexCom as of Q1 2023.

Based on Pearl River Capital's 13F filing for Q1 2023, filed 12 May 2023.